Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.

Twenty-six patients affected by Parkinson's disease were treated with a 2-Br-alpha-ergocriptine (CB 154): 14 cases were given CB 154 alone, and 12 were given CB 154 along with L-dopa plus benserazide (Madopar). Both CB 154 and combined therapy (CB 154+Madopar) induced a significant improvement...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Caraceni, T A, Celano, I, Parati, E, Girotti, F
Format: Artigo
Jezik:Inglês
Izdano: 1977
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC492936/
https://ncbi.nlm.nih.gov/pubmed/591982
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items